title: Lovastatin in X-linked adrenoleukodystrophy.
authors.forename: Marc
authors.initials: M
authors.lastname: Engelen
authors.forename: Rob
authors.initials: R
authors.lastname: Ofman
authors.forename: Marcel G W
authors.initials: MG
authors.lastname: Dijkgraaf
authors.forename: Michiel
authors.initials: M
authors.lastname: Hijzen
authors.forename: Lucinda A
authors.initials: LA
authors.lastname: van der Wardt
authors.forename: Bjorn M
authors.initials: BM
authors.lastname: van Geel
authors.forename: Marianne
authors.initials: M
authors.lastname: de Visser
authors.forename: Ronald J A
authors.initials: RJ
authors.lastname: Wanders
authors.forename: Bwee Tien
authors.initials: BT
authors.lastname: Poll-The
authors.forename: Stephan
authors.initials: S
authors.lastname: Kemp
mesh_terms: D000326:Adrenoleukodystrophy / Q000097:blood / Q000188:drug therapy*; D008078:Cholesterol, LDL / Q000097:blood; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005227:Fatty Acids / Q000032:analysis / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008148:Lovastatin / Q000627:therapeutic use*; D010865:Pilot Projects
chemical_list: D008078:Cholesterol, LDL; D005227:Fatty Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin; C017364:hexacosanoic acid; C010210:lignoceric acid